Small interfering RNA (siRNA) has a huge potential for the treatment or prevention of various lung diseases. Once the RNA molecules have successfully entered ...
Advances in device technology have led to the development of more efficient delivery systems capable of delivering larger doses and finer particles into the lung.
Advances in device technology have led to the development of more efficient delivery systems capable of delivering larger doses and finer particles into the lung.
The location of these receptors in the lung suggests that ipratropium bromide needs to be delivered to the conducting airways, while salbutamol requires a more ...
Modified delivery of SAPIEN 3 valve in the pulmonary position: Evolution of technique or dire need? Catheter Cardiovasc Interv. 2019 Feb 15;93(3):484-487. doi: ...
has suggested a growing need for a multidisciplinary approach to the delivery of ...
Aerosol delivery devices have evolved over more than 60 years from the basic pressurized metered-dose inhaler and nebulizer to numerous ...
A successful pulmonary administration requires a harmonic interaction between the drug formulation, the inhaler device, and the patient.
We have previously developed efficient peptide-based nucleic acid delivery vectors PF14 and NF55, where we have shown that these vectors ...
While oral delivery of tablets and capsules remains the preferred treatment modality for most patients, inhaled therapeutics have dominated the ...